Holt, attorney and owner of Holt Law, a health-care business law firm in Minnesota and California, points out that it was moved to Category 2 in 2023, so legally, compounding pharmacies cannot distribute it for human use. But theyre using that for research purposes loophole to distribute it
Exendin-4 has been shown to significantly enhance human beta-cell engraftment when used in combination with dual tyrosine-regulated kinase 1A inhibitor, harmine 44 , indicating its potential applicability for patients with T1D
Liability Disclaimer In no event shall the publisher, its officers, employees, or affiliates be liable for any direct, indirect, incidental, special, or consequential damages arising from or in connection with the use of the information contained in this publication
This neurological effect may help patients resist impulse eating and make more deliberate dietary choices